Global Rheumatology Therapeutics Market 2018-2022 | Increasing Prevalence of Rheumatic Disorders to Boost Demand | Technavio
LONDON--(BUSINESS WIRE)--Oct 4, 2018-- analysts forecast the global rheumatology therapeutics market to grow at a CAGR of over 4% during the forecast period, according to their latest market research report.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181004005452/en/
Technavio analysts forecast the global rheumatology therapeutics market to grow at a CAGR of over 4% by 2022. (Graphic: Business Wire)
The rising number of small molecules in the drug development pipeline is one of the major trends being witnessed in the . Small molecules are generally less expensive than the biologics and are likely to emerge soon. They will be affordable on a large scale by the patients with juvenile rheumatoid arthritis, axial spondylitis, and ankylosing spondylitis, which will drive the market growth.
According to Technavio analysts, one of the key factors contributing to the growth of the global rheumatology therapeutics market is the increasing prevalence of rheumatic disorders:
Global rheumatology therapeutics market: Increasing prevalence of rheumatic disorders
The global rheumatology therapeutics market is expected to grow during the forecast period owing to the increasing prevalence of rheumatic disorders.
According to a senior analyst at Technavio for research on infectious and rare diseases, “In March 2017, the CDC reported that 54.4 million adults had doctor-diagnosed arthritis in the US during 2013-2015. By 2040, approximately 78 million US adults aged 18 years and above are expected to have doctor-diagnosed arthritis.”
Global rheumatology therapeutics market: Segmentation analysis
The global rheumatology therapeutics market research report provides market segmentation by molecule type (biologicals and small molecules) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
The Americas held the largest share of the market in 2017, accounting for close to 44% share, followed by EMEA and APAC respectively. The growth of the region can be attributed to the increasing prevalence of rheumatoid disorders. The rheumatology therapeutics market in APAC is expected to witness a faster growth during the forecast period owing to the expected launch of small-molecule-based therapeutics.
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market LandscapeMarket ecosystem Market characteristics Market segmentation analysis
Market SizingMarket definition Market size and forecast
Five Forces Analysis
Geographical SegmentationRegional comparison Key leading countries
Vendor LandscapeVendors covered Vendor classification Market positioning of vendors Competitive scenario
is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at .
View source version on businesswire.com:https://www.businesswire.com/news/home/20181004005452/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL
SOURCE: Technavio Research
Copyright Business Wire 2018.
PUB: 10/04/2018 10:17 AM/DISC: 10/04/2018 10:17 AM